REFERENCES
1. Peters AL, Van Stein D, Vlaar AP. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention. British journal of haematology. 2015;170(5):597-614.
2. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet (London, England). 2013;382(9896):984-94.
3. Roubinian N. TACO and TRALI: biology, risk factors, and prevention strategies. Hematology American Society of Hematology Education Program. 2018;2018(1):585-94.
4. Peters AL, van Hezel ME, Juffermans NP, Vlaar AP. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. Blood reviews. 2015;29(1):51-61.
5. Andreu G, Boudjedir K, Muller JY, Pouchol E, Ozier Y, Fevre G, et al. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013. Transfusion medicine reviews. 2018;32(1):16-27.
6. Vlaar AP, Binnekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Critical care medicine. 2010;38(3):771-8.
7. Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, et al. An update of the transfusion-related acute lung injury (TRALI) definition. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2019.
8. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757-67.
9. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133(17):1840-53.
10. Roubinian NH, Looney MR, Kor DJ, Lowell CA, Gajic O, Hubmayr RD, et al. Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions. Transfusion. 2015;55(8):1838-46.
11. Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R. Targeting Transfusion-Related Acute Lung Injury: The Journey From Basic Science to Novel Therapies. Critical care medicine. 2018;46(5):e452-e8.
12. Ducharme-Crevier L, Lacroix J. Interleukin-1 Receptor Antagonist and Interleukin-1beta: Risk Marker or Risk Factor for Pediatric Acute Respiratory Distress Syndrome? Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2018;19(10):993-5.
13. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. The Journal of clinical investigation. 2003;111(12):1805-12.
14. Kapur R, Kim M, Shanmugabhavananthan S, Liu J, Li Y, Semple JW. C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury. Blood. 2015;126(25):2747-51.
15. Kapur R, Kim M, Rondina MT, Porcelijn L, Semple JW. Elevation of C-reactive protein levels in patients with transfusion-related acute lung injury. Oncotarget. 2016;7(47):78048-54.
16. Pechous RDJFic, microbiology i. With friends like these: the complex role of neutrophils in the progression of severe pneumonia. 2017;7:160.
17. McNamara R, Deane AM, Anstey J, Bellomo R. Understanding the rationale for parenteral ascorbate (vitamin C) during an acute inflammatory reaction: a biochemical perspective. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2018;20(3):174-9.
18. Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Critical care (London, England). 2017;21(1):300.
19. Margaritelis NV, Paschalis V, Theodorou AA, Vassiliou V, Kyparos A, Nikolaidis MG. Rapid decreases of key antioxidant molecules in critically ill patients: A personalized approach. Clinical nutrition (Edinburgh, Scotland). 2019.
20. Carr AC, Maggini SJN. Vitamin C and immune function. 2017;9(11):1211.
21. Hartmann SE, Waltz X, Kissel CK, Szabo L, Walker BL, Leigh R, et al. Cerebrovascular and ventilatory responses to acute isocapnic hypoxia in healthy aging and lung disease: effect of vitamin C. Journal of applied physiology (Bethesda, Md : 1985). 2015;119(4):363-73.
22. Gaweł S, Wardas M, Niedworok E, Wardas P. [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiadomosci lekarskie (Warsaw, Poland : 1960). 2004;57(9-10):453-5.
23. Reynolds PS, Fisher BJ, McCarter J, Sweeney C, Martin EJ, Middleton P, et al. Interventional vitamin C: A strategy for attenuation of coagulopathy and inflammation in a swine multiple injuries model. The journal of trauma and acute care surgery. 2018;85(1S Suppl 2):S57-s67.
24. Washko P, Rotrosen D, Levine MJJoBC. Ascorbic acid transport and accumulation in human neutrophils. 1989;264(32):18996-9002.
25. Evans RM, Currie L, Campbell AJBJoN. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. 1982;47(3):473-82.
26. Corpe CP, Lee J-H, Kwon O, Eck P, Narayanan J, Kirk KL, et al. 6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. 2005;280(7):5211-20.
27. Vissers M, Hampton MJBST. The role of oxidants and vitamin C on neutrophil apoptosis and clearance. 2004;32(3):499-501.
28. Wang Y, Lin H, Lin BW, Lin JD. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Annals of intensive care. 2019;9(1):58.
29. Rozemeijer S, Spoelstra-de Man AME, Coenen S, Smit B, Elbers PWG, de Grooth H-J, et al. Estimating Vitamin C Status in Critically Ill Patients with a Novel Point-of-Care Oxidation-Reduction Potential Measurement. Nutrients. 2019;11(5):1031.
30. Fowler AA, 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. Jama. 2019;322(13):1261-70.
31. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Critical care medicine. 2005;33(4):721-6.
32. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774-89.
33. de Grooth HJ, Manubulu-Choo WP, Zandvliet AS, Spoelstra-de Man AME, Girbes AR, Swart EL, et al. Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens. Chest. 2018;153(6):1368-77.
34. Fowler AA, III, Fisher BJ, Kashiouris MG. Vitamin C for Sepsis and Acute Respiratory Failure—Reply. Jama. 2020;323(8):792-3.
35. Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Annals of intensive care. 2021;11(1):5.
36. Klimant E, Wright H, Rubin D, Seely D, Markman M. Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Current oncology (Toronto, Ont). 2018;25(2):139-48.
37. Fowler AA, 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32-.
38. Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas JJC. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. 2017;151(6):1229-38.
39. Al Sulaiman K, Al Juhani O, Salah KB, Badreldin HA, Al Harthi A, Alenazi M, et al. Ascorbic Acid as an Adjunctive Therapy in Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study. 2021.
40. Li W, Maeda N, Beck MAJTJon. Vitamin C deficiency increases the lung pathology of influenza Virus–Infected gulo−/− mice. 2006;136(10):2611-6.
41. Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Wegelin JA, Brophy D, et al. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. 2012.
42. Kashiouris MG, L’Heureux M, Cable CA, Fisher BJ, Leichtle SWJN. The emerging role of vitamin C as a treatment for sepsis. 2020;12(2):292.
43. Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. 2019;322(13):1261-70.
44. Marik PE, Payen D. CITRIS-ALI: how statistics were used to obfuscate the true findings. 2019.
45. Hemilä H, Chalker EJJoic. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis. 2020;8(1):1-9.
46. JamaliMoghadamSiahkali S, Zarezade B, Koolaji S, SeyedAlinaghi S, Zendehdel A, Tabarestani M, et al. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. 2021;26(1):1-9.
47. Wang Y, Lin H, Lin B-w, Lin J-dJAoic. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. 2019;9(1):1-13.
48. Carr AC, Shaw GM, Natarajan RJCC. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? 2015;19(1):1-8.
49. Zabet MH, Mohammadi M, Ramezani M, Khalili HJJoripp. Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. 2016;5(2):94.
50. Li M, Ching TH, Hipple C, Lopez R, Sahibzada A, Rahman H. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection. 2021;0(0):08971900211015052.
51. Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. 2014;12(1):1-10.
52. Ferrón-Celma I, Mansilla A, Hassan L, Garcia-Navarro A, Comino A-M, Bueno P, et al. Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery. 2009;153(2):224-30.
53. de Grooth H-J, Manubulu-Choo W-P, Zandvliet AS, Spoelstra-de Man AM, Girbes AR, Swart EL, et al. Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four IV regimens. 2018;153(6):1368-77.
54. McNamara R, Deane AM, Anstey J, Bellomo RJCC, Resuscitation. Understanding the rationale for parenteral ascorbate (vitamin C) during an acute inflammatory reaction: a biochemical perspective. 2018;20(3):174-9.